Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Dayton & Montgomery County Public Health hosted its ninth annual “Rocking our Red Pumps” event on Friday to recognize ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...

Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...